Hyperphosphorylation and insolubility of α-synuclein in transgenic mouse oligodendrocytes

被引:240
作者
Kahle, PJ [1 ]
Neumann, M
Ozmen, L
Müller, V
Jacobsen, H
Spooren, W
Fuss, B
Mallon, B
Macklin, WB
Fujiwara, H
Hasegawa, M
Iwatsubo, T
Kretzschmar, HA
Haass, C
机构
[1] Univ Munich, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, D-80336 Munich, Germany
[2] Univ Munich, Dept Neuropathol, D-81377 Munich, Germany
[3] F Hoffmann La Roche & Co Ltd, Pharma Res, CH-4002 Basel, Switzerland
[4] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA
[5] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 1130033, Japan
关键词
D O I
10.1093/embo-reports/kvf109
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
(Oligodendro)glial cytoplasmic inclusions composed of alpha-synuclein (alphaSYN) characterize multiple system atrophy (MSA). Mature oligodendrocytes (OLs) do not normally express alphaSYN, so MSA pathology may arise from aberrant expression of alphaSYN in OLs. To study pathological deposition of alphaSYN in OLs, transgenic mice were generated in which human wild-type alphaSYN was driven by a proteolipid protein promoter. Transgenic alphaSYN was detected in OLs but no other brain cell type. At the light microscopic level, the transgenic alphaSYN profiles resembled glial cytoplasmic inclusions. Strikingly, the diagnostic hyperphosphorylation at S129 of alphaSYN was reproduced in the transgenic mice. A significant proportion of the transgenic alphaSYN was detergent insoluble, as in MSA patients. The histological and biochemical abnormalities were specific for the disease-relevant alphaSYN because control green fluorescent protein was fully soluble and evenly distributed throughout OL cell bodies and processes. Thus, ectopic expression alphaSYN in OLs might initiate salient features of MSA pathology.
引用
收藏
页码:583 / 588
页数:6
相关论文
共 27 条
[1]   NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy [J].
Arima, K ;
Uéda, K ;
Sunohara, N ;
Arakawa, K ;
Hirai, S ;
Nakamura, M ;
Tonozuka-Uehara, H ;
Kawai, M .
ACTA NEUROPATHOLOGICA, 1998, 96 (05) :439-444
[2]   The solubility of α-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease [J].
Campbell, BCV ;
McLean, CA ;
Culvenor, JG ;
Gai, WP ;
Blumbergs, PC ;
Jäkälä, P ;
Beyreuther, K ;
Masters, CL ;
Li, QX .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (01) :87-96
[3]   Widespread alterations of α-synuclein in multiple system atrophy [J].
Dickson, DW ;
Liu, WK ;
Hardy, J ;
Farrer, M ;
Mehta, N ;
Uitti, R ;
Mark, M ;
Zimmerman, T ;
Golbe, L ;
Sage, J ;
Sima, A ;
D'Amato, C ;
Albin, R ;
Gilman, S ;
Yen, SH .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) :1241-1251
[4]   Immunohistochemical and biochemical studies demonstrate a distinct profile of α-synuclein permutations in multiple system atrophy [J].
Duda, JE ;
Giasson, BI ;
Gur, TL ;
Montine, TJ ;
Robertson, D ;
Biaggioni, I ;
Hurtig, HI ;
Stern, MB ;
Gollomp, SM ;
Grossman, M ;
Lee, VMY ;
Trojanowski, JQ .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (09) :830-841
[5]   α-Synuclein is phosphorylated in synucleinopathy lesions [J].
Fujiwara, H ;
Hasegawa, M ;
Dohmae, N ;
Kawashima, A ;
Masliah, E ;
Goldberg, MS ;
Shen, J ;
Takio, K ;
Iwatsubo, T .
NATURE CELL BIOLOGY, 2002, 4 (02) :160-164
[6]   Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein [J].
Fuss, B ;
Mallon, B ;
Phan, T ;
Ohlemeyer, C ;
Kirchhoff, F ;
Nishiyama, A ;
Macklin, WB .
DEVELOPMENTAL BIOLOGY, 2000, 218 (02) :259-274
[7]  
Gai WP, 1999, J NEUROCHEM, V73, P2093
[8]   Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions [J].
Giasson, BI ;
Duda, JE ;
Murray, IVJ ;
Chen, QP ;
Souza, JM ;
Hurtig, HI ;
Ischiropoulos, H ;
Trojanowski, JQ ;
Lee, VMY .
SCIENCE, 2000, 290 (5493) :985-989
[9]   Consensus statement on the diagnosis of multiple system atrophy [J].
Gilman, S ;
Low, PA ;
Quinn, N ;
Albanese, A ;
Ben-Shlomo, Y ;
Fowler, CJ ;
Kaufman, H ;
Klockgether, T ;
Lang, AE ;
Lantos, PL ;
Litvan, I ;
Mathias, CJ ;
Oliver, E ;
Robertson, D ;
Schatz, I ;
Wenning, GK .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 163 (01) :94-98
[10]   Multiple system atrophy - The putative causative role of environmental toxins [J].
Hanna, PA ;
Jankovic, J ;
Kirkpatrick, JB .
ARCHIVES OF NEUROLOGY, 1999, 56 (01) :90-94